This HTML5 document contains 213 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n12http://dx.doi.org/10.1128/

Statements

Subject Item
wd:Q34058294
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ 2014年论文 научни чланак vedecký článok wissenschaftlicher Artikel articolo scientifico artykuł naukowy 2014年論文 научни чланак 2014年论文 artikulong pang-agham vitskapeleg artikkel مقالة علمية 2014年论文 artículu científicu espublizáu en 2014 2014年論文 2014년 논문 2014年论文 tieteellinen artikkeli 2014年论文 mokslinis straipsnis научна статия wetenschappelijk artikel 2014年の論文 article scientifique (publié 2014) наукова стаття, опублікована в травні 2014 vědecký článek სამეცნიერო სტატია article scientific επιστημονικό άρθρο bilimsel makale scientific article 2014年論文 ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2014年論文 artigo científico (publicado na 2014) artikull shkencor 2014 թուականի Մայիսին հրատարակուած գիտական յօդուած 2014 թվականի մայիսին հրատարակված գիտական հոդված videnskabelig artikel (udgivet 2014) bài báo khoa học naučni članak مقالهٔ علمی artículo científico publicado en 2014 2014 nî lūn-bûn artigo científico 2014年論文 tudományos cikk บทความทางวิทยาศาสตร์ 2014年论文 научная статья scienca artikolo teaduslik artikkel article científic سائنسی مضمون articol științific artigo científico (publicado na 2014) מאמר מדעי мақолаи илмӣ vitenskapelig artikkel vetenskaplig artikel
p:P577
wds:Q34058294-6406C05D-3E1B-4E50-AFAF-FF886B16D8E1
wdt:P577
2014-05-27T00:00:00Z
p:P407
wds:Q34058294-6570A7E5-AB10-4157-8FA4-19796693B5BE
wdt:P407
wd:Q1860
p:P2860
wds:Q34058294-00CBF796-FFAD-487C-87E7-E090D0C498D5 wds:Q34058294-1265B2BA-7C54-41D2-9221-F898D0CC0C13 wds:Q34058294-177111FE-ECEF-441B-90A3-C001B4E103E5 wds:Q34058294-18188EFA-D591-4F09-94BD-B407F6EC1885 wds:Q34058294-07DCD3FD-FDAB-4B47-A74D-CC52DB578DEB wds:Q34058294-32AF0E7B-2244-4E04-97F9-8C5B3CC11D6E wds:Q34058294-3B90524A-D639-462D-B7CF-39D93A7EEF2C wds:Q34058294-26DD353B-50B4-4063-B7AE-D4E4C0C570E1 wds:Q34058294-2E8C4658-323F-47A0-B01E-13B1D3A1F1AE wds:Q34058294-49F11FEF-834C-4A7A-808D-75ADEAFEBE25 wds:Q34058294-4A734947-0E01-4BD8-A483-F2AD21FD0B24 wds:Q34058294-4CA10518-64E8-4438-89E6-B86A65869EBF wds:Q34058294-4011D54A-4C7B-4875-AFE1-3E02881279D7 wds:Q34058294-438B196D-3AD8-4DF4-BAA4-DCB4A3C96C36 wds:Q34058294-490C5E7F-C6DA-472F-AA1C-A289BE35AF86 wds:Q34058294-5FE683D2-B1C8-4D7B-BD11-22F2887F9D90 wds:Q34058294-664BA32F-D098-437D-848F-0B52BDB5F5A2 wds:Q34058294-515783FD-2D98-4AC8-BBBF-F24FFCC7E11A wds:Q34058294-54CD30D4-0E2C-4193-95CD-3C0EC190ABDA wds:Q34058294-7A474136-3CAA-472D-9FE1-63DE4632F8A8 wds:Q34058294-7A4D1D28-A6D8-4052-B7E1-8020351638A7 wds:Q34058294-7D4F4F01-77B5-476B-B575-E43A1C895E22 wds:Q34058294-7F3A0148-70BE-43DF-A1CA-83A15520F3D7 wds:Q34058294-6A680E9F-061F-45EB-845E-E3B92EBE151D wds:Q34058294-6EC43143-EA2E-4241-9623-BFBCA92B2353 wds:Q34058294-702FB532-5948-476F-ABFB-26DF8BB77BE4 wds:Q34058294-740FA457-7BA5-40BA-AB7E-1783EDFDDE8A wds:Q34058294-93C9CAD4-05A3-480E-812F-B76D13DFBA13 wds:Q34058294-81187245-A672-4184-82AE-EE488054443C wds:Q34058294-86D4FDF3-1B1B-4E6D-97BE-1FC2E0BE0DF6 wds:Q34058294-B0839D41-C0AA-4CEB-AB60-1A06B792C7EE wds:Q34058294-B66E0298-9A73-4BE0-84A2-66F518FB9393 wds:Q34058294-AABC7D0F-BBDE-4316-9FCB-0225F3AD1E04 wds:Q34058294-AB8C4B5A-4023-477E-A5BD-0A9F6A4BA7CA wds:Q34058294-AC4DC2DA-F821-4099-971E-6BE5208BE119 wds:Q34058294-AE8B2F60-68F0-4FAE-AE69-011F8B923C0E wds:Q34058294-CC2F0C67-B5C0-4E5B-9C77-A3D147B762DD wds:Q34058294-D4600850-69FC-4F67-B840-F7B103F58F4D wds:Q34058294-D602DD9A-50F3-4AB4-88C4-8FC0E8BE92AE wds:Q34058294-D9D2523F-DF5B-4534-BAB5-0B59297AFB54 wds:Q34058294-BD615484-644A-48F1-98B5-2CD4DFA1BB68 wds:Q34058294-C4ECE931-1B77-4CD2-82C1-C675758B1878 wds:Q34058294-CB7E77B9-F3EA-40F9-90F6-8E0BD1EE24E8 wds:Q34058294-E84557FE-F7E8-48B9-8D22-03D1C4ACE022 wds:Q34058294-D9EF57F4-EEC1-4833-87D8-FA95482AF018 wds:Q34058294-E09F83CF-35FF-4F92-BD39-03D27044D330 wds:Q34058294-E2F8EB22-5FAF-4604-B417-D089D41D4195 wds:Q34058294-E578242F-C9B9-499D-8B81-1587E817BD5C
wdt:P2860
wd:Q34933034 wd:Q36405446 wd:Q58846629 wd:Q45207817 wd:Q43937388 wd:Q37263574 wd:Q48454254 wd:Q28534313 wd:Q36369970 wd:Q35848986 wd:Q34321754 wd:Q36625874 wd:Q38884830 wd:Q37781017 wd:Q56135184 wd:Q38015023 wd:Q42432966 wd:Q37894699 wd:Q33834072 wd:Q34692088 wd:Q38905072 wd:Q47827460 wd:Q36143432 wd:Q58845422 wd:Q36816566 wd:Q37392888 wd:Q28477800 wd:Q28484117 wd:Q37659077 wd:Q45127824 wd:Q36079376 wd:Q37801690 wd:Q42710547 wd:Q24612184 wd:Q36835020 wd:Q46677554 wd:Q38905903 wd:Q33798222 wd:Q39286815 wd:Q48809535 wd:Q37317284 wd:Q30481757 wd:Q39416311 wd:Q44618905 wd:Q38912264 wd:Q39099156 wd:Q34868070 wd:Q39212746
p:P2093
wds:Q34058294-B18C1A9D-4518-40B6-A05F-1AB105ADB2AD wds:Q34058294-5360541F-E09C-45EB-BC84-D0083B517B94 wds:Q34058294-4D67BF27-87B0-4AA3-A64A-DE231F09F8CB wds:Q34058294-08E6B59A-3DA2-4CF2-9E97-8E903E05E229 wds:Q34058294-0B368F1A-0B27-49A1-8A93-B545D51292D5
wdt:P2093
Richard R Tidwell Michael Zhuo Wang Reto Brun Donald A Patrick David W Boykin
rdfs:label
In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness
skos:prefLabel
In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness
schema:name
In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness
p:P50
wds:Q34058294-1259498D-BFEC-4DA0-B390-D8AE81B03FB7 wds:Q34058294-93070B26-BC1D-4AA3-9EDF-A62F059A8DCB wds:Q34058294-9756B056-5D33-44A4-9C0A-1E96C1096F07 wds:Q34058294-4F3B93BB-4EB3-40A8-BE47-122B777B2544
wdt:P50
wd:Q57052465 wd:Q58833564 wd:Q42433071 wd:Q39025786
p:P1476
wds:Q34058294-304A743B-778D-4DF3-A5A7-6C179C1212B2
wdt:P1476
In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness
p:P304
wds:Q34058294-196B72B4-539D-420C-8D3B-E78BC256365D
wdt:P304
4452-4463
p:P31
wds:Q34058294-321B2A2D-354C-435E-8686-5BE7EACF4279
wdt:P31
wd:Q13442814
p:P921
wds:Q34058294-8E94C9B8-B016-4A59-AFAE-3BE0F7CAECFC
wdt:P921
wd:Q203133
p:P698
wds:Q34058294-31AE0B56-8C41-4CFD-898E-166D35CA11C6
wdtn:P698
n11:24867978
wdt:P698
24867978
p:P1433
wds:Q34058294-BDAAE454-687D-4E04-9341-C52B7A94FBF0
wdt:P1433
wd:Q578004
p:P433
wds:Q34058294-3F9BD01B-999D-4A06-80C0-478517D8DB86
p:P478
wds:Q34058294-00CD4BC4-DCE5-40AF-BCFC-E7F10B141C5A
wdt:P433
8
wdt:P478
58
p:P356
wds:Q34058294-90917902-6CFC-4F87-A0C4-62D2558DF9D5
wdtn:P356
n12:AAC.02309-13
wdt:P356
10.1128/AAC.02309-13
p:P5875
wds:Q34058294-A993FC21-892F-4018-8E8A-33C40F3AAE18
wdt:P5875
262682862
p:P932
wds:Q34058294-B1101103-B7BB-49A8-B077-AA920E529C26
wdt:P932
4136055